(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TERAPIA COMBINADA COM ANTI-GARP-TGF- B1/PD-1

Em AnáliseInvention PatentPCT · IB2023057715

Application data

Number

112025001301

Type

Invention Patent

Filing

07/28/2023

Publication

06/24/2025

PCT

IB2023057715

Progress at the INPI

  1. Filing07/28/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 07/28/2023. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 06/24/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ABBVIE BIOTHERAPEUTICS INC.

US

ABBVIE DEUTSCHLAND GMBH & CO. KG

DE

See this company's full portfolio

Inventors

B. E. (pessoa física)

DE

C. F. (pessoa física)

US

J. O. (pessoa física)

US

J. S. (pessoa física)

US

M. B. (pessoa física)

US

M. P. (pessoa física)

US

S. K. (pessoa física)

US

Technical data

Priority claims

US

63/369,931 · 07/29/2022

Abstract

TERAPIA COMBINADA COM ANTI-GARP-TGF- ?1/PD-1. A presente invenção se refere a métodos de tratamento de câncer com a combinação de um anticorpo do complexo anti-TGF-ß1/GARP e um anticorpo anti-PD-1.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

06/24/2025

RPI 2842

Alteração de dados cadastrais

#1.1

02/04/2025

RPI 2822

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.